Anthropic & Eli Lilly and Company

Anthropic: Anthropic>>> is a rival to OpenAI>>> and is also pushing towards public markets, indicating a trend in the AI sector.

Eli Lilly and Company: Eli Lilly and Company>>> advanced after positive trial results for its next-generation obesity drug, retatrutide, which showed benefits beyond weight loss.

Anthropic: Anthropic is an anchor partner with RaiseMe, participating in the initiative to prepare the workforce for the changes brought about by artificial intelligence.

Eli Lilly and Company: Eli Lilly is an employer involved in the RaiseMe project, contributing to the nonprofit's goal of adapting the workforce to an AI economy.

Anthropic: Anthropic is one of the AI heavyweights expected to follow SpaceX with an IPO, and its performance will be closely watched as a bellwether for investor appetite in the AI sector. SpaceX is also renting out its AI computing capacity to Anthropic.

Eli Lilly and Company: Eli Lilly and Company is mentioned as one of the companies that SpaceX's valuation will surpass, emphasizing the magnitude of SpaceX's market entry.